Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolism

[1]  A. Mukhopadhyay,et al.  Pan-cancer classification by regularized multi-task learning , 2021, Scientific Reports.

[2]  C. Swanton,et al.  Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  J. Mu,et al.  Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation , 2021, Cell Death & Disease.

[4]  Annette S. Kim,et al.  Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia. , 2020, Cancer cell.

[5]  Apekshya Panda,et al.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..

[6]  K. Fisher-Wellman,et al.  Novel approach to quantify mitochondrial content and intrinsic bioenergetic efficiency across organs , 2020, Scientific Reports.

[7]  Jun Yu,et al.  In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. , 2020, Gastroenterology.

[8]  Ming Y. Lu,et al.  AI-based pathology predicts origins for cancers of unknown primary , 2020, Nature.

[9]  Yin Yuan,et al.  Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma , 2020, Cancer Cell International.

[10]  Yingyong Hou,et al.  SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling. , 2020, American journal of cancer research.

[11]  I. Kovalenko,et al.  SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism , 2020, Oncotarget.

[12]  H. Lee,et al.  A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. , 2019, Cell metabolism.

[13]  R. Deberardinis,et al.  Leveraging insights into cancer metabolism—a symposium report , 2019, Annals of the New York Academy of Sciences.

[14]  H. Christofk,et al.  In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer , 2019, Nature.

[15]  Stephen J. Elledge,et al.  Tissue-specificity in cancer: The rule, not the exception , 2019, Science.

[16]  N. Kim,et al.  Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation , 2019, EBioMedicine.

[17]  R. Deberardinis,et al.  Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. , 2018, Cell metabolism.

[18]  Shumeng Ji.  Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis. , 2018, Medecine sciences : M/S.

[19]  Joshua M. Dempster,et al.  Genetic and transcriptional evolution alters cancer cell line drug response , 2018, Nature.

[20]  V. Seshan,et al.  Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo , 2018, Nature Biotechnology.

[21]  Le Yin,et al.  Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide , 2018, Oncogene.

[22]  M. Scalise,et al.  Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth , 2017, Front. Oncol..

[23]  K. Garber.  In a major shift, cancer drugs go 'tissue-agnostic'. , 2017, Science.

[24]  Roland Rad,et al.  Tissue-specific tumorigenesis: context matters , 2017, Nature Reviews Cancer.

[25]  Mark Lee,et al.  Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection , 2017, Cell.

[26]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[27]  Purushottam D. Dixit,et al.  Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers , 2016, Science.

[28]  Karl R. Clauser,et al.  MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins , 2015, Nucleic Acids Res..

[29]  A. Karlsson,et al.  The mitochondrial carrier SLC25A10 regulates cancer cell growth , 2015, Oncotarget.

[30]  J. Settleman,et al.  From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue , 2014, Cell.

[31]  Huaxi Xu,et al.  Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells , 2014, Oncology letters.

[32]  D. Vitkup,et al.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network , 2013, Nature Biotechnology.

[33]  David A. Orlando,et al.  Revisiting Global Gene Expression Analysis , 2012, Cell.

[34]  Abhishek K. Jha,et al.  Functional genomics reveals serine synthesis is essential in PHGDH-amplified breast cancer , 2011 .

[35]  W. Kunz.  Different Metabolic Properties of Mitochondrial Oxidative Phosphorylation in Different Cell Types ‐ Important Implications for Mitochondrial Cytopathies , 2003, Experimental physiology.

[36]  H. Kolbe,et al.  Mitochondrial phosphate transport. Large scale isolation and characterization of the phosphate transport protein from beef heart mitochondria. , 1984, The Journal of biological chemistry.

[37]  Joshua I Gold,et al.  Context Matters , 2004, Neuron.

[38]  F. Santorelli,et al.  BACTERIAL EXPRESSION, RECONSTITUTION, FUNCTIONAL CHARACTERIZATION, AND TISSUE DISTRIBUTION OF TWO HUMAN ISOFORMS* , 2003 .

[39]  A. Schoolwerth,et al.  Metabolite transport in mitochondria. , 1979, Annual review of biochemistry.